Trademarkia Logo

Australia

AU$
GALXC
Protected: Registered/protected

Last updated on 27 Jan 2022

Owner Info

Dicerna Pharmaceuticals, Inc.

87 Cambridgepark Drive

Cambridge MA 02140, UNITED STATES OF AMERICA

Serial Number

2213099 filed on 16 Jul 2021

Correspondent

Bridget H. Labutta Panitch Schwarze

Two Commerce Square,,

2001 Market Street,,

UNITED STATES OF AMERICA

GALXC

Classification Information


Class [005]
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, card Read More

Class [040]
Custom manufacture of oligonucleotides.

Class [042]
Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of r Read More

Mark Details


Serial Number

2213099

Registered On

16 Jul 2021

Renewal On

16 Jul 2031

Mark Type

WORD

Priority Claim (Convention Details)


Date

17 Feb 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
27th Jan 2022Amendment to International Registration Contact Requested
14th Dec 2021International Registration in Australia Protected correspondence sent
13th Dec 2021IP Right Registration Published
13th Dec 2021Status change to Registered/Protected
6th Oct 2021Application Accepted correspondence sent
5th Oct 2021IP Right has been Examined
5th Oct 2021IP Right Acceptance Published
5th Oct 2021Status change to Accepted
28th Sept 2021Examination expedited
28th Sept 2021Awaiting examination